Delivery Order SPE2DB20D3505-SPE2DB21FT4B7
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,091.76, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA worth up to $999,999,999.00 through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive assortment of medications,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,975.48, is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, worth up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, supports the supply of a comprehensive range of medical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,394.64, is a delivery order under an Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with the DLA. This IDC serves as the primary vehicle for the company to deliver pharmaceutical and medical supplies,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of a comprehensive range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,412.17, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,265.02, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,128.72, is a delivery order under an Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and AmerisourceBergen, worth up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,775.64, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,190.94, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 and running through November 2026. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of pharmaceutical and medical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,127.30, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA that is valued at up to $999,999,999 and runs through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,157.37, is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc. The IDC with the DLA is valued up to $999,999,999.00 and runs through November...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB21FT4B7Delivery Order
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides a wide range of pharmaceutical products and medical supplies valued at $1,377.46 to support the Defense Logistics Agency (DLA) Troop Support Medical program. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, that runs through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to deliver essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's parent company, Cencora, Inc., also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/7/20 |